BNP Paribas Financial Markets
LSTA icon

BNP Paribas Financial Markets’s Lisata Therapeutics LSTA Stock Holding History

BNP Paribas Financial Markets’s Portfolio LSTA Stock Details LSTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-4
Closed -$1.46K – 3587
2015
Q1 		$1.46K Buy
+4
New +$2.17K ﹤0.01% 3524
2014
Q4 		– Sell
-9
Closed -$7.86K – 2662
2014
Q3 		$7.86K Buy
+9
New +$7.88K ﹤0.01% 3700

Other funds holding LSTA

GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

BNP Paribas Financial Markets's LSTA Position: Q2 2015 in Review

BNP Paribas Financial Markets sold out of Lisata Therapeutics (LSTA) in Q2 2015, closing a stake of 4 shares — an estimated $1.46K sold.

BNP Paribas Financial Markets first reported a position in LSTA in Q3 2014 and held it in 2 quarters. The position peaked at $7.86K in Q3 2014. 51 funds tracked by Wall St. Rank hold LSTA as of Q2 2015.

  • BNP Paribas Financial Markets reported no remaining Lisata Therapeutics position as of Q2 2015 after selling out during the quarter.
  • BNP Paribas Financial Markets sold 4 Lisata Therapeutics shares in Q2 2015, an estimated $1.46K.
  • BNP Paribas Financial Markets first reported a position in Lisata Therapeutics in Q3 2014 and held it in 2 quarters.
  • BNP Paribas Financial Markets's Lisata Therapeutics position peaked at $7.86K in Q3 2014.
  • 51 funds tracked by Wall St. Rank held Lisata Therapeutics as of Q2 2015.

Based on BNP Paribas Financial Markets's 13F filing for Q2 2015, filed 14 Aug 2015.